Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to determine whether cognitive behavioral therapy (CBT) is effective in the treatment of attention deficit and emotional, executive function and social function dysregulation due to attention deficit disorder (ADHD).
Participations will be randomly assigned to 3 groups which are CBT with booster sessions group, CBT only group and waiting group.With the comparison of first tow groups we will explore the effect of booster sessions, and the last two groups the effect of CBT programme.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| CBT with booster sessions | Experimental | Participants will receive 12 cognitive-behavioral therapy sessions weekly and 3 booster sessions monthly following our protocol. |
|
| CBT only | Active Comparator | Participants will only receive 12 cognitive-behavioral therapy sessions weekly. |
|
| waiting | No Intervention | Participations will not be treated with CBT and keep waiting for 12 weeks for comparison. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| CBT only | Behavioral | Participants will learn 12 sessions including educational information about ADHD and skills in organization and plan, reducing distractibility, and adaptive thinking. |
| Measure | Description | Time Frame |
|---|---|---|
| Change in ADHD Rating Scale | ADHD symptom severity as measured by the ADHD rating scale (DuPaul, et al., 1998) a scale that ranges from 0-54 with 0 indicating lower severity. | Baseline, at the end of week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and 11 in treatment, 12 weeks (post), 24 weeks (FU6), 36 weeks (FU9), and 48 weeks (FU12) |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Conners Adult ADHD Rating Scale Self-report Screening Version (CAARS-S:SV) | The CAARS-S:SV is a self-reported scale measures the ADHD symptom severity including 30 items rating from 0 to 3. | Baseline, at the end of week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and 11 in treatment, 12 weeks (post), 24 weeks (FU6), 36 weeks (FU9), and 48 weeks (FU12) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Qiujin Qian, PhD | Peking University Sixth Hospital | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Peking University Sixth Hospital | Beijing | Beijing Municipality | 100191 | China |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 25873090 | Derived | Huang F, Qian Q, Wang Y. Cognitive behavioral therapy for adults with attention-deficit hyperactivity disorder: study protocol for a randomized controlled trial. Trials. 2015 Apr 14;16:161. doi: 10.1186/s13063-015-0686-1. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001289 | Attention Deficit Disorder with Hyperactivity |
| ID | Term |
|---|---|
| D019958 | Attention Deficit and Disruptive Behavior Disorders |
| D065886 | Neurodevelopmental Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| CBT with booster sessions | Behavioral | Participants are provided with the same CBT programme and additional 3 booster sessions which summarize and extend the 3 main topics of the CBT programme in order to improve the skills practice ability. |
|
| Change in Self-Rating Anxiety Scale (SAS) | The Self-Rating Anxiety Scale (SAS) with 20 items measures the level of anxiety. | Baseline, at the end of week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and 11 in treatment, 12 weeks (post), 24 weeks (FU6), 36 weeks (FU9), and 48 weeks (FU12) |
| Change in Self-rating depression scale (SDS) | The Self-rating depression scale (SDS) is used to measure the level of depression. | Baseline, at the end of week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and 11 in treatment, 12 weeks (post), 24 weeks (FU6), 36 weeks (FU9), and 48 weeks (FU12) |
| Change in Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A) | The BRIEF-A measures the impairment level of executive function in ADHD adults. | Baseline, 12 weeks (post), 24 weeks (FU6), and 48 weeks (FU12) |
| Change in Cambridge Neuropsychological Test Automatic Battery (CANTAB) | The CANTAB is a computerized neuropsychological test measuring the cognitive and executive function. | Baseline, 12 weeks (post), 24 weeks (FU6), and 48 weeks (FU12) |
| Change in Barratt impulsiveness scale (BIS) | The Barratt impulsiveness scale including 30 items is used to measure impulsiveness. | Baseline, 12 weeks (post), 24 weeks (FU6), and 48 weeks (FU12) |
| Change in self-esteem scale (SES) | The self-esteem scale measures the level of self-esteem. | Baseline, 12 weeks (post), 24 weeks (FU6), and 48 weeks (FU12) |
| Change in World Health Organization Quality of Life-Brief Version (WHOQOL-BREF) | The WHOQOL-BREF is the short version of World Health Organization Quality of Life scale and includes 26 items measuring the level of life quality. | Baseline, 12 weeks (post), 24 weeks (FU6), and 48 weeks (FU12) |
| Change in Brain Oxygenation Level Dependent (BOLD) Signal | The level of BOLD activity during working memory task after CBT is compared with baseline level to explore the potential effects of CBT on brain. | Baseline, 12 weeks (post) |